Status:

COMPLETED

FODMAP Reintroduction in Irritable Bowel Syndrome

Lead Sponsor:

University of California, Los Angeles

Conditions:

Irritable Bowel Syndrome With Diarrhea

Irritable Bowel Syndrome With Mixed Bowel Habits

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to determine the amount and timing of when certain Fermentable Oligo-Di-Monosaccharides and Polyols (FODMAPs), specifically fructose, can be safely reintroduced into the d...

Detailed Description

Research supports clinical experience that ingestion of food often triggers the emergence or exacerbation of symptoms in the majority of patients with irritable bowel syndrome (IBS). While IBS remains...

Eligibility Criteria

Inclusion

  • Adults (18+ years or older) with a diagnosis of IBS-D or IBS-M based on Rome IV criteria
  • Diarrhea must occur 2 or more days per week
  • Patients on current pharmacological therapy for their gastrointestinal complaints can enroll in the study as long as they have been on a stable dose for at least 30 days.

Exclusion

  • Significant comorbidities that are associated with GI symptoms (e.g. diabetes, scleroderma, SLE), history of GI surgery excluding appendectomy, or prior organic GI illness
  • Antibiotics taken in the past 2 months
  • Current disordered eating patterns (diagnosed eating disorder; as per verbal ESP questionnaire)
  • Current history of greater than moderate alcohol intake (more than 1 drink per day for women, more than 2 drinks per day for men, binge drinking behavior of 5+ drinks in a single session once per week)
  • Cannot have had a cholecystectomy in the past 6 months prior to enrollment

Key Trial Info

Start Date :

March 24 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2023

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT03245645

Start Date

March 24 2017

End Date

June 30 2023

Last Update

July 11 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UCLA

Los Angeles, California, United States, 90095